ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

OGEN Oragenics Inc

1.02
0.00 (0.00%)
プレマーケット
最終更新日: 20:00:00
15分遅延
名称 銘柄コード 市場 種別
Oragenics Inc OGEN AMEX 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 1.02 20:00:00
始値 安値 高値 終値 前日終値
1.02
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2006:50BWOragenics, Inc. Announces Notification of Noncompliance with..
2024/4/0122:05BWOragenics, Inc. Files 10K and Provides Company Update
2024/3/1820:00BWOragenics Appoints James Kelly MD, Chief Medical Officer, to..
2024/3/0706:24EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/3/0521:45BWOragenics, Inc. Prepares Drug for Phase II Clinical Trials..
2024/3/0206:04BWOragenics Announces Closing of Public Offering
2024/3/0106:41EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/2823:03EDGAR2Form 8-K - Current report
2024/2/2811:25BWOragenics Announces Pricing of Public Offering
2024/2/2807:09EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
2024/2/2807:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/2806:33BWOragenics Announces Proposed Public Offering
2024/2/1310:06EDGAR2Form SC 13D - General statement of acquisition of beneficial..
2024/2/1306:45EDGAR2Form 8-K - Current report
2024/2/1306:41BWOragenics, Inc. Announces Leadership Transition
2024/2/0722:00EDGAR2Form 8-K - Current report
2024/2/0722:00BWOragenics, Inc. Announces Expiration of Its Investment..
2024/2/0522:00EDGAR2Form 8-K - Current report
2024/2/0522:00BWOragenics, Inc. Preparing for Phase II Clinical Trials to..
2024/1/2407:34BWOragenics Announces Termination of At-The-Market Offering..
2024/1/2407:18EDGAR2Form 8-K - Current report
2024/1/2307:30EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
2024/1/1623:10EDGAR2Form 8-K - Current report
2024/1/1623:08EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
2024/1/1623:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/1/1106:37EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/1/0307:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0223:22EDGAR2Form 8-K - Current report
2024/1/0221:30BWOragenics Completes Acquisition of Odyssey Health’s..
2023/12/2921:30EDGAR2Form 8-K - Current report
2023/12/1605:45EDGAR2Form 8-K - Current report
2023/12/0906:00EDGAR2Form 8-K - Current report
2023/12/0207:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0107:50EDGAR2Form 144 - Report of proposed sale of securities
2023/11/2105:45EDGAR2Form 8-K - Current report
2023/11/1704:37EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/11/0220:00EDGAR2Form 8-K - Current report
2023/11/0220:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/11/0220:00BWOragenics Issues Update to Shareholders
2023/10/3105:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/10/3105:00EDGAR2Form DEF 14A - Other definitive proxy statements
2023/10/1821:30BWOragenics Announces Appointment of Bruce Cassidy and John..
2023/10/0705:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0705:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0705:28EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/10/0705:25EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/10/0606:29EDGAR2Form 8-K - Current report
2023/10/0519:30EDGAR2Form 8-K - Current report
2023/10/0519:30BWOragenics to Acquire Odyssey Health’s Neurological Drug..
2023/9/3005:00EDGAR2Form 8-K - Current report

最近閲覧した銘柄

Delayed Upgrade Clock